Pharmaceutical Technologies

The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment


Genentech and Immunocore to jointly develop cancer treatment

Immunocore Limited (UK), a leading T Cell Receptor biotechnology company, announced it has entered into a new partnership with Genentech (USA) to expand an existing discovery collaboration.

Takeda entered into drug discovery collaboration with Cardiff University

Cardiff University (Wales, UK) has formed a drug discovery collaboration with Takeda to identify new approaches for treating schizophrenia and other psychiatric disorders.

Lonza launches its Collaborative Innovation Center in Israel

Lonza Pharma & Biotech officially opens its Collaborative Innovation Center (CIC) in the Haifa Life Science Park (Israel).
clinical trials

R-Pharm reported positive results from Phase III clinical trial of remimazolam

R-Pharm Group and the Specialty Pharma Company PAION AG (Germany) announced that the Phase III trial in general anesthesia conducted in Russia has been successfully completed.
David Rarl

Dara Pharma: Modern Pharmaceutical Equipment from Spain

One of the key factors that ensure that the manufacturers of drugs comply with GMP standards, is the implementation of modern technological equipment in their production plants which will be subsequen...

MorphoSys signed agreement with I-Mab for a novel immuno-oncology agent

MorphoSys and I-Mab Biopharma, a biotech company focused on onimmuno-oncology and autoimmune diseases, jointly announced that they have entered into an exclusive strategic collaboration

German Federal Minister of Health calls for faster deployment of biosomilars

Jens Spahn, Germany'sFederal Minister of Health of Germany, has stated in his recent interview that there should be faster uptake of biosimilars in Germany for cancer and autoimmune diseases.

Boehringer Ingelheim and Epizyme will develop new epigenetic cancer therapies

Boehringer Ingelheim and Epizyme announced a new global collaboration focused on the research of novel small molecule inhibitors directed toward two previously unaddressed epigenetic targets.


Expert opinion